Literature DB >> 25074787

Safety of intravenous iron formulations: facts and folklore.

Michael Auerbach1, Iain C Macdougall2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25074787      PMCID： PMC4111808          DOI： 10.2450/2014.0094-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  42 in total

1.  Clinical update: intravenous iron for anaemia.

Authors:  Michael Auerbach; Harold Ballard; John Glaspy
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

2.  A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.

Authors:  E Bisbe; J A García-Erce; A I Díez-Lobo; M Muñoz
Journal:  Br J Anaesth       Date:  2011-09       Impact factor: 9.166

3.  Comparative rates of adverse events with different formulations of intravenous iron.

Authors:  Maureen M Okam; Elyse Mandell; Nathanael Hevelone; Rachel Wentz; Ainsley Ross; Gregory A Abel
Journal:  Am J Hematol       Date:  2012-09-11       Impact factor: 10.047

4.  Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients.

Authors:  Brian A J Walters; David B Van Wyck
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

Review 5.  Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.

Authors:  G Faich; J Strobos
Journal:  Am J Kidney Dis       Date:  1999-03       Impact factor: 8.860

6.  A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.

Authors:  Markus R Jahn; Hans B Andreasen; Sören Fütterer; Thomas Nawroth; Volker Schünemann; Ute Kolb; Wolfgang Hofmeister; Manuel Muñoz; Klaus Bock; Morten Meldal; Peter Langguth
Journal:  Eur J Pharm Biopharm       Date:  2011-03-23       Impact factor: 5.571

7.  Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Jorge Cuenca; José Antonio García-Erce; Daniel Iglesias-Aparicio; Sami Haman-Alcober; Daniel Ariza; Enrique Naveira
Journal:  Transfusion       Date:  2013-04-15       Impact factor: 3.157

8.  Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?

Authors:  Tansu Sav; Bulent Tokgoz; Murat Hayri Sipahioglu; Murat Deveci; Ismail Sari; Oktay Oymak; Cengiz Utas
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

9.  Intravenous iron dextran in clinical medicine.

Authors:  R D Hamstra; M H Block; A L Schocket
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

Review 10.  Iron toxicity: relevance for dialysis patients.

Authors:  Steven Fishbane; Anna Mathew; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2013-10-28       Impact factor: 5.992
View more
  36 in total

1.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

2.  To the rescue: the role of intravenous iron in the management of severe anaemia in the peri-partum setting.

Authors:  Bernd Froessler; Gustaaf Dekker; Georgina Mcauliffe
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

3.  The Italian Regulatory Guidelines for the implementation of Patient Blood Management.

Authors:  Stefania Vaglio; Sara Gentili; Giuseppe Marano; Simonetta Pupella; Daniela Rafanelli; Gianni Biancofiore; Paola Antonioli; Claudio Velati; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-05-03       Impact factor: 3.443

4.  Treating iron deficiency.

Authors:  Michelle P Zeller; Madeleine Verhovsek
Journal:  CMAJ       Date:  2016-12-19       Impact factor: 8.262

Review 5.  The Labile Side of Iron Supplementation in CKD.

Authors:  Itzchak Slotki; Zvi Ioav Cabantchik
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

6.  Intravenous iron and safety: is the end of the debate on the horizon?

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-07       Impact factor: 3.443

7.  Iron: a double-edged sword.

Authors:  Lyla A Youssef; Steven L Spitalnik
Journal:  Transfusion       Date:  2017-10       Impact factor: 3.157

Review 8.  Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department.

Authors:  Julia G Ramos; Michelle P Zeller
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 9.  Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Authors:  Manish Saha; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

10.  Management of Iron Deficiency Anemia.

Authors:  Kristine Jimenez; Stefanie Kulnigg-Dabsch; Christoph Gasche
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.